Serum S100A12 levels are correlated with clinical severity in patients with dermatomyositis-associated interstitial lung disease

OBJECTIVE: S100A12 is an emerging inflammatory disease biomarker. Interstitial lung disease (ILD) is a common, severe complication of dermatomyositis (DM). This study was performed to investigate the association between S100A12 and disease activity and prognosis in patients with DM-associated ILD (i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Yueyan, Zheng, Yu, Fan, Bijun, Zhang, Liyan, Zhu, Feng, Wang, Xiaodong, Chen, Zhiwei, Tan, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607057/
https://www.ncbi.nlm.nih.gov/pubmed/31865833
http://dx.doi.org/10.1177/0300060519887841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607057/
https://www.ncbi.nlm.nih.gov/pubmed/31865833
http://dx.doi.org/10.1177/0300060519887841

Ejemplares similares